|
Mechanism4-1BBL inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Chengdu Shengshi Junlian Biotechnology Co., Ltd.
0 Patents (Medical) associated with Chengdu Shengshi Junlian Biotechnology Co., Ltd.
100 Deals associated with Chengdu Shengshi Junlian Biotechnology Co., Ltd.
100 Translational Medicine associated with Chengdu Shengshi Junlian Biotechnology Co., Ltd.